Bayer | BAYN - Selling And Administration Expenses

Stock Price
43.68
Daily Change
-1.90 -4.16%
Monthly
-1.10%
Yearly
96.09%
Q1 Forecast
42.20

Bayer reported EUR3.4B in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Air Liquide EUR 2.57B 1.27B Dec/2024
Akzo Nobel EUR 811M 28M Dec/2025
Alcon AG USD 865M 5M Sep/2025
Amarin USD 17.94M 17.86M Sep/2025
Arkema EUR 231M 11M Sep/2025
AstraZeneca USD 4.61B 4.46B Dec/2025
BASF EUR 2.2B 384M Sep/2025
Bayer EUR 3.4B 140M Sep/2025
Beiersdorf EUR 322M 1.68B Jun/2025
Corteva USD 860M 135M Dec/2025
Covestro EUR 437M 12M Sep/2025
Essilor EUR 5.62B 4.53B Dec/2025
Fresenius EUR 676M 64M Sep/2025
Fresenius Medical Care EUR 705.44M 86.56M Sep/2025
Genmab DKK 144M 18M Jun/2025
Givaudan CHF 294.5M 229.5M Jun/2024
GlaxoSmithKline GBP 2.68B 518M Dec/2025
GRIFOLS EUR 284.99M 2.24M Sep/2025
Henkel EUR 3.45B 213M Jun/2025
Hikma Pharmaceutical USD 139M 149M Jun/2025
Johnson Matthey GBP 170M 87M Dec/2025
Linde USD 840M 30M Sep/2025
Merck EUR 1.46B 16M Sep/2025
Novartis USD 3.31B 134M Sep/2025
Nutrien USD 981M 36M Dec/2025
Philips EUR 1.31B 127M Dec/2025
PPG Industries USD 905M 71M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Sanofi EUR 2.75B 455M Dec/2025
SAP EUR 2.63B 78M Dec/2025
Solvay EUR 115M 1000K Sep/2025
UCB EUR 1.29B 221M Dec/2024
Vinci EUR 197M 49M Jun/2025